Osemozotan
From Wikipedia, the free encyclopedia
 |
|
|---|---|
| Systematic (IUPAC) name | |
| 5-(3-[((2S)-1,4-benzodioxan-2-ylmethyl)amino]propoxy)-1,3-benzodioxole | |
| Clinical data | |
| Pregnancy cat. | ? |
| Legal status | Uncontrolled |
| Identifiers | |
| CAS number | 137275-80-0 |
| ATC code | ? |
| PubChem | CID 198746 |
| UNII | M65825806Q  |
| Chemical data | |
| Formula | C20H23NO4 |
| Mol. mass | 341.400 g/mol |
| SMILES | eMolecules & PubChem |
 (what is this?) (verify) |
Osemozotan (MKC-242) is a selective 5-HT1A receptor agonist with some functional selectivity, acting as a full agonist at presynaptic and a partial agonist at postsynaptic 5-HT1A receptors.[1] It has antidepressant and anxiolytic effects in animal studies,[2][3] and is used to investigate the role of 5-HT1A receptors in modulating the release of dopamine and serotonin in the brain,[4][5] and their involvement in addiction to abused stimulants such as cocaine and methamphetamine.[6][7][8][9][10]
[edit] See also
[edit] References
- ^ Matsuda, T; Yoshikawa, T; Suzuki, M; Asano, S; Somboonthum, P; Takuma, K; Nakano, Y; Morita, T et al. (1995). "Novel benzodioxan derivative, 5-(3-((2S)-1,4-benzodioxan-2- ylmethyl)aminopropoxy)-1,3-benzodioxole HCl (MKC-242), with a highly potent and selective agonist activity at rat central serotonin1A receptors.". Japanese journal of pharmacology 69 (4): 357–66. doi:10.1254/jjp.69.357. PMID 8786639.
- ^ Abe, M; Tabata, R; Saito, K; Matsuda, T; Baba, A; Egawa, M (1996). "Novel benzodioxan derivative, 5-3-((2S)-1,4-benzodioxan-2-ylmethyl) aminopropoxy-1,3-benzodioxole HCl (MKC-242), with anxiolytic-like and antidepressant-like effects in animal models". The Journal of pharmacology and experimental therapeutics 278 (2): 898–905. PMID 8768745.
- ^ Sakaue, M.; Ago, Y.; Sowa, C.; Koyama, Y.; Baba, A.; Matsuda, T. (2003). "The 5-HT1A receptor agonist MKC-242 increases the exploratory activity of mice in the elevated plus-maze". European journal of pharmacology 458 (1–2): 141–144. doi:10.1016/S0014-2999(02)02786-3. PMID 12498918.
- ^ Sakaue, M.; Somboonthum, P.; Nishihara, B.; Koyama, Y.; Hashimoto, H.; Baba, A.; Matsuda, T. (2000). "Postsynaptic 5-hydroxytryptamine1A receptor activation increases in vivo dopamine release in rat prefrontal cortex". British journal of pharmacology 129 (5): 1028–1034. doi:10.1038/sj.bjp.0703139. PMC 1571922. PMID 10696105. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=1571922.
- ^ Ago, Y; Koyama, Y; Baba, A; Matsuda, T (2003). "Regulation by 5-HT1A receptors of the in vivo release of 5-HT and DA in mouse frontal cortex". Neuropharmacology 45 (8): 1050–6. doi:10.1016/S0028-3908(03)00304-6. PMID 14614948.
- ^ Ago, Y.; Nakamura, S.; Uda, M.; Kajii, Y.; Abe, M.; Baba, A.; Matsuda, T. (2006). "Attenuation by the 5-HT1A receptor agonist osemozotan of the behavioral effects of single and repeated methamphetamine in mice". Neuropharmacology 51 (4): 914–922. doi:10.1016/j.neuropharm.2006.06.001. PMID 16863654.
- ^ Ago, Y.; Nakamura, S.; Hayashi, A.; Itoh, S.; Baba, A.; Matsuda, T. (2006). "Effects of osemozotan, ritanserin and azasetron on cocaine-induced behavioral sensitization in mice". Pharmacology, biochemistry, and behavior 85 (1): 198–205. doi:10.1016/j.pbb.2006.07.036. PMID 16962650.
- ^ Ago, Y.; Nakamura, S.; Baba, A.; Matsuda, T. (2008). "Neuropsychotoxicity of abused drugs: effects of serotonin receptor ligands on methamphetamine- and cocaine-induced behavioral sensitization in mice". Journal of pharmacological sciences 106 (1): 15–21. doi:10.1254/jphs.FM0070121. PMID 18198473.
- ^ Tsuchida, R.; Kubo, M.; Kuroda, M.; Shibasaki, Y.; Shintani, N.; Abe, M.; Köves, K.; Hashimoto, H. et al. (2009). "An antihyperkinetic action by the serotonin 1A-receptor agonist osemozotan co-administered with psychostimulants or the non-stimulant atomoxetine in mice". Journal of pharmacological sciences 109 (3): 396–402. doi:10.1254/jphs.08297FP. PMID 19270432.
- ^ Tsuchida, R; Kubo, M; Shintani, N; Abe, M; Köves, K; Uetsuki, K; Kuroda, M; Hashimoto, H et al. (2009). "Inhibitory effects of osemozotan, a serotonin 1A-receptor agonist, on methamphetamine-induced c-Fos expression in prefrontal cortical neurons". Biological & pharmaceutical bulletin 32 (4): 728–31. doi:10.1248/bpb.32.728. PMID 19336914.
 |
This drug article relating to the nervous system is a stub. You can help Wikipedia by expanding it. |
